SCHEMBL2315928

SCHEMBL2315928

O=C1c2ccccc2C(=O)c2c1ccc(CCO)c2CCO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.49
MEN1 O00255 10/20 0.46
KMT2A Q03164 10/20 0.46
PABPC1 P11940 1/20 0.46
MAPT P10636 8/20 0.46
ALDH1A1 P00352 6/20 0.46
MAPK1 P28482 6/20 0.46
MAOA P21397 3/20 0.46
RECQL P46063 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MCL1 Q07820 2/20 0.46
CYP3A4 P08684 2/20 0.46
KDM4E B2RXH2 1/20 0.46
BCL2 P10415 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
APEX1 P27695 1/20 0.46
DAPK1 P53355 1/20 0.46
CYP1B1 Q16678 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2313177 0.82 MEN1 (0.48) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL16145028 0.82 ALDH1A1 (0.58) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL3266102 0.82 MAOA (0.57) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL2316204 0.81 MEN1 (0.54) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL30849360 0.76 ELANE (0.56) ELANEMAPTALDH1A1MAPK1SMN1; SMN2
SCHEMBL17294122 0.75 ELANE (0.43) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL2313485 0.74 MAOA (0.48) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL2311188 0.74 BCL2 (0.54) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL3798382 0.74 MAPK1 (0.50) ELANEMEN1KMT2APABPC1MAPT
SCHEMBL8359453 0.73 MEN1 (0.55) ELANEMEN1KMT2APABPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed